Development of a novel oral delivery system of edaravone for enhancing bioavailability

scientific article published on 24 October 2016

Development of a novel oral delivery system of edaravone for enhancing bioavailability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJPHARM.2016.10.052
P698PubMed publication ID27789367

P50authorSanjay GargQ37831335
Xin-Fu ZhouQ47432909
P2093author name stringAnkit Parikh
Chun Chuan Tan
Krishna Kathawala
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectedaravoneQ335099
bioavailabilityQ461809
P304page(s)490-500
P577publication date2016-10-24
P1433published inInternational Journal of PharmaceuticsQ6051539
P1476titleDevelopment of a novel oral delivery system of edaravone for enhancing bioavailability
P478volume515

Reverse relations

cites work (P2860)
Q30844551A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
Q92134746Assessment of Fractional Factorial Design for the Selection and Screening of Appropriate Components of a Self-nanoemulsifying Drug Delivery System Formulation
Q57181453Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability
Q47700268How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
Q38699643Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
Q55686117Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement.
Q60706687Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model
Q88437167Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics

Search more.